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Abstract
Background: Human interfollicular epidermis is sustained by the proliferation of stem cells and
their progeny, transient amplifying cells. Molecular characterization of these two cell populations is
essential for better understanding of self renewal, differentiation and mechanisms of skin
pathogenesis. The purpose of this study was to obtain gene expression profiles of alpha 6+/MHCI+,
transient amplifying cells and alpha 6+/MHCI-, putative stem cells, and to compare them with
existing data bases of gene expression profiles of hair follicle stem cells. The expression of Major
Histocompatibility Complex (MHC) class I, previously shown to be absent in stem cells in several
tissues, and alpha 6 integrin were used to isolate MHCI positive basal cells, and MHCI low/negative
basal cells.
Results: Transcriptional profiles of the two cell populations were determined and comparisons
made with published data for hair follicle stem cell gene expression profiles. We demonstrate that
presumptive interfollicular stem cells, alpha 6+/MHCI- cells, are enriched in messenger RNAs
encoding surface receptors, cell adhesion molecules, extracellular matrix proteins, transcripts
encoding members of IFN-alpha family proteins and components of IFN signaling, but contain lower
levels of transcripts encoding proteins which take part in energy metabolism, cell cycle, ribosome
biosynthesis, splicing, protein translation, degradation, DNA replication, repair, and chromosome
remodeling. Furthermore, our data indicate that the cell signaling pathways Notch1 and NF-κB are
downregulated/inhibited in MHC negative basal cells.
Conclusion: This study demonstrates that alpha 6+/MHCI- cells have additional characteristics
attributed to stem cells. Moreover, the transcription profile of alpha 6+/MHCI- cells shows
similarities to transcription profiles of mouse hair follicle bulge cells known to be enriched for stem
cells. Collectively, our data suggests that alpha 6+/MHCI- cells may be enriched for stem cells. This
study is the first comprehensive gene expression profile of putative human epithelial stem cells and
their progeny that were isolated directly from neonatal foreskin tissue. Our study is important for
understanding self renewal and differentiation of epidermal stem cells, and for elucidating signaling
pathways involved in those processes. The generated data base may serve those working with
other human epithelial tissue progenitors.
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Background
Skin constantly renews throughout adult life. The prolifer-
ative compartment of epidermis is confined to the basal
layer, where it harbors stem cells, and their progeny, tran-
sient amplifying cells [1-3]. Stem cells are predominantly
quiescent in situ. Transient amplifying cells are more rap-
idly cycling, and after dividing for a limited period of time
cease to proliferate and undergo terminal differentiation
while moving towards the skin surface [4]. Slow cycling
stem cells of the murine epidermis were identified by the
retention of BrdU or [3H]thymidine after prolonged chase
[5-9]. Research aimed at isolating stem cells directly from
human tissue has to be based on different methodological
approaches. Putative human interfollicular stem cells
have been enriched based on the expression of β1 integrin
[10], transferin receptor [11], connexin 43 [12], an iso-
form of CD133 [13] and desmosomal proteins [14]. How-
ever, it has not been determined whether these cells
represent distinct populations, or belong to overlapping
cell subsets. Databases generated from gene expression
profiles of stem cells provide useful resources in evaluat-
ing putative stem cell populations. The lack or low levels
of MHCI molecules have been reported in stem cells of
several tissues [15-20]. Downregulation of MHCI tran-
scripts has been observed in mouse hair follicle stem cells
[21]. We have previously isolated a subpopulation of
human basal keratinocytes with low/negative MHCI
expression (α6+/MHCI-) [22]. Cells with α6+/MHCI- phe-
notype constitute a small fraction of the basal layer (0.5–
2%) as determined by flow cytometry [22]. We found that
α6+/MHCI- cells were keratinocytes as they expressed ker-
atin 14 (K14). The α6+/MHCI- cells exhibited characteris-
tics attributed to stem cells: they were clonogenic in vitro,
relatively small, and had low granularity [22]. In the
present work we employ microarray technology, to report
global transcriptional profiles of two cell populations: the
basal cells that express MHCI, α6+/MHCI+  (transient
amplifying cells) and the basal cells that have low/nega-
tive MHCI expression, α6+/MHCI- cells, (putative stem
cells). Cells were isolated using fluorescence-activated cell
sorter (FACS) directly from human epidermis. Further
comparisons were made with published data of hair folli-
cle stem cell gene expression profiles.
In addition, using flow cytometry we have analyzed the
expression of nuclear proliferation antigen, Ki67. Our
data indicate that MHCI- cells are quiescent in situ. Follow-
ing FACS sorting, α6+/MHCI-and α6+/MHCI+ cells were
grown at clonal densities to determine their colony form-
ing efficiency (CFE). The analysis of CFEs in the initial,
primary, culture and in the first passage indicate that α6+/
MHCI- cells have higher proliferative potential than α6+/
MHCI+ cells, another feature attributed to stem cells.
Results and discussion
Skin is the largest and most accessible organ in the body.
The differentiation axis of the interfollicular epidermis is
spatially well defined: the basal layer contains proliferat-
ing cells, while suprabasal layers, stratum spinosum, stra-
tum granulosum, and stratum corneum harbor post-
mitotic, differentiating keratinocytes [23,24]. These fea-
tures facilitate the analysis of cells at the specific differen-
tiation stage. Like all self-renewing tissues, epidermis
contains stem cells, which are located in the stratum
basale. Several proteins have been suggested as markers
for keratinocyte stem cell enrichment [10-14]. We have
previously described a basal keratinocyte population that
lacks gap junction protein Cx43 in human and mouse epi-
dermis [12]. We have shown that Cx43 negative cells co-
localize with label-retaining cells, hair follicle bulge stem
cells [6-8]. Cx43 negative keratinocytes comprise about
10% of human basal keratinocytes and are blast like,
small and have low granularity as determined by flow
cytometry. Cells in the limbus of the eye, the region of the
corneal epithelium that contains stem cells, were also
shown to lack Cx43 [25]. In searching for additional
markers that can be used to obtain viable cells, we isolated
a subset of Cx43 negative keratinocytes characterized by
low/negative expression of MHCI that comprised up to
2% of basal epidermal cells [22]. It was believed that
almost all nucleated cells express MHCI [26]. Recently,
however, stem cells of several tissues were shown to lack
MHCI expression [15-21]. Molecules encoded by MHC
are involved in self/non-self discrimination in vertebrates.
MHCI molecules bind endogenously derived peptides
and stimulate a distinct branch of the adaptive immune
system mediated by CD8+  T cells. The human MHC
termed HLA (Human Leukocyte Antigen) encodes three
classical polymorphic class I genes: HLA A, B, and C. To
isolate transient amplifying cells (α6+/MHCI+) and pre-
sumptive stem cells (α6+/MHCI-), we used antibodies
against α6 integrin, a basal cell marker, in combination
with antibodies against β2 microglobulin, the light chain
of MHCI molecule. Previously we have shown that similar
results were obtained regardless of whether antibodies to
MHCI heavy chain, or antibodies against β2 microglobu-
lin were used [22].
α6+/MHCI- cells are quiescent in situ, yet in culture display 
higher proliferative potential
During tissue homeostasis stem cells are infrequently
dividing; thus, and one of the characteristics of stem cells
is their quiescence in situ. To determine the proliferative
status of MHCI- and MHCI+populations, we analyzed the
expression of nuclear proliferation antigen Ki67, which is
a marker for actively cycling cells. The data presented
reflect keratinocyte proliferation since in normal epider-
mis, non keratinocytes are found to be non-cycling
[27,28]. Although the absolute values of Ki67 may varyBMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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depending on the total number of gated cells, the ratio of
Ki67 expressing MHCI- and MHCI+ cells is held constant.
Flow cytometric analysis showed that MHCI+  cells
expressed more than four time higher levels of Ki67 than
MHCI-  cells (Figure 1). Only 0.9% of MHCI-  cells
expressed Ki67, while 3.9% of MHCI+cells were in the cell
cycle. Given the low percentages of MHCI-cells in the
basal layer, it is clear that the bulk of cell production in the
epidermis is accomplished through divisions of transient
amplifying cells, a finding which is in accordance with the
established view of epidermal homeostasis.
High proliferative potential is another feature of stem
cells. One way of assessing proliferative potential of kerat-
inocytes is to analyze their colony forming efficiency
(CFE) [10]. To assess proliferative potential of the two cell
populations' colony forming efficiency (CFE) was ana-
lyzed in the primary and secondary cultures. Sorted cells
were seeded at clonal densities and colonies formed eval-
uated after two weeks. In primary cultures, α6+/MHCI-
cells exhibited lower colony forming efficiency than α6+/
MHCI+ cells (Figure 2). However, in secondary cultures
α6+/MHCI- showed higher CFE than α6+/MHCI+ cells.
From primary to secondary culture, an increase of 38
times was observed in the CFE of α6+/MHCI- cells, while
the CFE of α6+/MHCI+ cells increased only 3.6 times (Fig-
ure 2). Previously, lower initial CFE was observed in lim-
bal epithelial stem cell [29]. Our data indicate that α6+/
MHCI- cells have higher proliferative potential than α6+/
MHCI+  cells, another characteristic attributed to stem
cells. The majority of available data regarding CFE are
from secondary or tertiary keratinocyte cultures [10,30].
In the secondary cultures, α6+/MHCI- cells did display
higher CFE than α6+/MHCI+ cells, which is an indication
of a higher proliferative potential of the α6+/MHCI- cells
[10]. The lower CFE of α6+/MHCI- cells compared to α6+/
MHCI+ cells that we recorded in our primary cultures may
be due to the time needed for stem cells to transit from a
quiescent to a proliferative state.
Gene expression profile indicates that α6+/MHCI- cells 
exhibit properties of stem cells
Microarray profiles of stem cells and their progeny pro-
vide a global view into differences of expression of a large
number of genes and enable analyses of molecular proc-
esses involved in self renewal, proliferation and differen-
tiation. Gene expression profiles of hair follicle bulge
stem cells were recently reported [9,21,31-33], yet until
now no data are available with regard to human interfol-
licular keratinocyte stem cells. We report on transcrip-
tional profiles of putative human keratinocyte stem cells
and their immediate progeny, transient amplifying cells.
Global gene expression profile was obtained from sorted
α6+/MHCI- cells and α6+/MHCI+ cells using DNA microar-
ray chips. We identified a comprehensive list of differen-
tially expressed genes. Notably, all of the MHCI genes
were downregulated in α6+/MHCI- cells, thus confirming
the successful separation of α6+/MHCI+ and α6+/MHCI-
cells. The data also show that expression of MHCI pro-
teins in keratinocytes is regulated at the transcriptional
level. The HLA-E transcript is downregulated in α6+/
MHCI- cells confirming our previous results obtained at
the protein level [22]. The expression of non-classical HLA
molecules is thought to protect cells that lack classical
HLA expression from lysis by NK cells. At present, it is not
known what mechanisms protect presumptive stem cells,
MHCI- cells, from attack by NK cells, especially since
MHCI- cells do not express detectable levels of non-classi-
cal HLA-E and HLA-G molecules [22].
We found that most of the mRNAs of genes encoding cel-
lular receptors and other cell surface molecules were more
abundant in α6+/MHCI- cells than in α6+/MHCI+ cells
(see Additional file 1). Conversely, mRNAs of genes
encoding proteins that take part in ribosome biosynthesis,
RNA splicing, translation, protein degradation, and
energy metabolism were more abundant in α6+/MHCI+
cells (see Additional file 1). These findings are consistent
MHCI negative cells express low levels of Ki67 Figure 1
MHCI negative cells express low levels of Ki67. (A) A 
representative flow cytometric analysis of the expression of 
proliferation antigen Ki67 in MHCI positive, and MHCI nega-
tive cells. Gates were set using isotype control antibodies 
and single color control antibodies. In this experiment 3.9% 
of MHCI positive cells express Ki67, while only 0.9% of 
MHCI negative cells express Ki67. Although the exact values 
of proliferating population may vary from experiment to 
experiment the ratio of MHCI positive and MHCI negative 
proliferating populations stay constant. This result demon-
strate quiescent nature of MHCI negative cells. (B) Single 
positive isotype control for PE. (C) Single positive control for 
FITC. (D) Secondary control.
A B
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with reports by other investigators who demonstrated that
stem cells are characterized by few ribosomes and mito-
chondria (features related to undifferentiated state of stem
cells) but contain a large numbers of receptors [9,34].
In reference to stem cells quiescence, it should also be
noted that transcripts of CDKN1C and CDKN2A whose
products are cyclin-dependent kinase inhibitors were
enriched in α6+/MHCI- cells (Figure 3A). The product of
CDKN1C, p57Kip2, one of the Cip/Kip family members, is
tightly associated with inhibition of proliferation of
human interfollicular keratinocytes [35], and is upregu-
lated in hair follicle bulge [31], while the product of
CDKN2A, a 16 kDa protein p16INK4a imposes a G1 cell
cycle arrest [36,37]. Furthermore, in addition to the low
protein level of Ki67 observed in MHCI negative popula-
tion (Figure 1), the transcript of Ki67 was less abundant in
α6+/MHCI- cells (Table 1, and Additional file 1). Con-
versely, transcripts of genes encoding proteins that are
related to cell proliferation such as cyclins, proteins
involved in chromosome remodeling, DNA replication
and repair were preferentially enriched in α6+/MHCI+
cells (Table 1, and Additional file 1).
Interestingly, type I IFN (IFN-α, and IFN-β) has been
shown to inhibit cell proliferation by inducing G1 cell
cycle arrest. It has been reported that interferon α (IFN-α)
has antiproliferative effects on bone marrow stromal pre-
Comparison of colony forming efficiencies of α6+/MHCI+ and α6+/MHCI- cells Figure 2
Comparison of colony forming efficiencies of α6+/MHCI+ and α6+/MHCI- cells. A representative experiment of the 
colony forming efficiency (CFE) of sorted α6+/MHCI+ cells and α6+/MHCI- cells cultured on 3T3 fibroblast feeder layer. Pri-
mary culture of α6+/MHCI- cells exhibits lower CFE than α6+/MHCI+ cells. However, secondary culture of α6+/MHCI- cells 
exhibits higher CFE than α6+/MHCI+ cells (*P < 0.001). The CFE of α6+/MHCI+ cells increased ~3.6× from primary to second-
ary culture, while it increased ~38× for α6+/MHCI-. These results indicate higher proliferative potential of α6+/MHCI- cells 
compared to α6+/MHCI+ cells. Cells directly sorted by FACS (from niche, i.e. primary cultures) were seeded at the following 
concentrations: α6+/MHCI+ cells, 3,000 cells per plate; α6+/MHCI- cells, 10,000 cells per plate. It must be noted that even 
though higher cell number was plated for α6+/MHCI- cells in the primary cultures, the CFE of these cells was lower than the 
CFE of α6+/MHCI+ cells. In secondary cultures equal numbers of cells were plated (100 cells per plate) for both, α6+/MHCI+ 
cells, and α6+/MHCI- cells.BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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cursors, hepatic progenitor cells, and mesenchymal stem
cells [39-41]. We observed enrichment of transcripts of
the IFN-α family of proteins in α6+/MHCI- cells as well as
STAT2, the specific transducing activator of IFN-α tran-
scription. This is the first report that suggests involvement
of type I IFN in epidermal stem cell quiescence. Further
studies are needed to determine whether IFN-α is synthe-
sized by α6+/MHCI- cells, whether its pathway is active
and whether it contributes to α6+/MHCI- cell quiescence
(Table 1).
It has been reported that the components of the inositol
phospholipid signaling system are present and that the
system itself is active in murine embryonic stem cells [42].
In the present study, we demonstrate that several compo-
nents of the inositol phospholipid signaling system are
enriched in α6+/MHCI- cells (Table 1). Nevertheless, the
functional significance of this observation needs further
investigation.
Among the transcripts enriched in α6+/MHCI- cells, there
were transcripts previously shown to be upregulated in
cell population enriched for human interfollicular stem
cells, such as α6 integrin [11], melanoma-associated
chondroitin sulfate proteoglycan [43], phosphorylase
kinase α2 [43], and the transcript of p53 homolog p51/
p73L/p63/p40  [44] (Figure 3A and Additional file 1).
Using flow cytometry we found that MHCI- cells expressed
lower level of transferrin receptor (CD71), a negative
marker used to enrich for interfollicular epidermal stem
cells [11], when compared to MHCI+ cells (Figure 4). It
should also be noted that although differences in the
expression of CD71  transcript were lower than 2 fold,
CD71 mRNA was downregulated in α6+/MHCI- cells com-
pared to α6+/MHCI+ cells consistently in both arrays (see
Additional file 2).
Among the transcripts enriched in α6+/MHCI+ cells, there
were mRNAs of genes whose products are expressed at low
levels in cell population enriched for human interfollicu-
lar stem cells, such as desmosomal proteins including des-
Expression of interfollicular epidermal stem cell markers in MHCI negative cells Figure 3
Expression of interfollicular epidermal stem cell markers in MHCI negative cells. (A) Differentially expressed genes 
identified by microarray analysis that were discussed in the text. The numbers shown are in fold change in log2 scale and are 
the highest score for the gene. (B) The differentially expressed genes identified by microarray analysis and/or known epidermal 
SC markers were confirmed using semi-quantitative RT-PCR. PCR was run for 25, 30, and 35 cycles. β-catenin mRNA, which 
did not show significant change of expression in the two cell populations was used as a control.
ABBMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
Page 6 of 15
(page number not for citation purposes)
moglein 3 (DSG3) [14], as well as the proliferation
associated transcription factor c-Myc, found to be
expressed at the lower levels in cultured human interfol-
licular stem cells [45] (Figures 3A, 3B and Additional file
1). Moreover, it has been reported that epidermal growth
factor receptor (EGFR) signaling is downregulated in
putative human interfollicular stem cells [43]. In accord-
ance with this observation, we found that EGFR itself was
downregulated in α6+/MHCI- cells (Fig. 3A and Addi-
tional file 1).
Most notably, we present results that demonstrate that
putative stem cells have lower expression of mRNAs
encoding proteins that take part in energy metabolism,
which can explain how stem cells can be quiescent and at
the same time maintain small size (see Additional file 1).
Comparison of α6+/MHCI- and α6+/MHCI+ microarray 
databases with the transcriptional profiles of human and 
mouse hair follicle stem cells
We compared α6+/MHCI- transcriptional profile with the
published transcriptional profile of human hair follicle
stem cells [32] and with four different sets of data of
murine hair follicle stem cells [9,21,31,33]. We found that
eleven genes, which were enriched in human hair follicle
stem cells, were also enriched in α6+/MHCI- cells (Table
1). Similarly, mRNAs of nine genes, which were downreg-
ulated in human hair follicle stem cells, were also down-
regulated in α6+/MHCI- cells (Table 2). Nevertheless, the
differences between the gene expression profiles of stem
cells from the two human tissues, i.e. interfollicular and
follicular, were also observed including the genes that
demonstrated two fold difference in the expression (total
of nine genes) (see Additional file 3).
mRNAs of eighty-two genes, which were enriched in
murine hair follicle stem cells, were also enriched in α6+/
MHCI- cells, while mRNAs of forty-one genes, which were
downregulated in murine hair follicle stem cells, were also
downregulated in α6+/MHCI- cells (Tables 1, 2 and Addi-
tional file 4). Transcription factors LHX2 and TCF3 that
were shown to maintain SC features [33,46], were among
the genes that were upregulated in α6+/MHCI- cells as well
as in murine hair follicle stem cells. Upon screening of our
microarray database for TCF3 targets [46], we found that
transcripts of twelve genes reported to be upregulated by
TCF3 were more abundant in α6+/MHCI- cells and con-
versely transcripts of nine genes repressed by TCF3 were
more abundant in α6+/MHCI+ cells (see Additional file 5).
Interestingly, both arrays that we performed showed that
LHX2 was among the most upregulated mRNAs in α6+/
MHCI- cells, while WIF-1  mRNA, which was the most
enriched mRNA in murine hair follicle stem cells accord-
ing to one report [33], was the mRNA that showed the
highest difference of expression between α6+/MHCI- cells
and α6+/MHCI+ cells (97 fold).
Table 1: Selected genes enriched in α6+/MHCI+ cells compared to α6+/MHCI- cells.
Factors downregulated in HHFSC CDC2 (1.7), PRC1 (1.6), RRM2 (2.3), ZWINT (1.1), KPNA2 (1.1), FEN1 (1.1), TOP2A (4.5), TYMS (1), 
RHEB2 (1.2).
Factors downregulated in MHFSC THBD (1.1), RBMS1 (4.2), MYC (1), ABCD4 (1.8), UGP2 (1.6), IGFBP3 (1.1), WNT3 (3.8), WNT4 (3.6), 
DSC2 (1.8), HSPA1A (2.4), CKMT1 (1), RORA (2.4), ANXA1 (1.4), ANXA2 (1.8), COL17A1 (2.2), IL6ST 
(1.7), TGFBR2 (1.3), LGALS7 (1.8), KRT5 (1), KRT15 (1.2), SERPINB2 (1), SERPINB7 (1.8), GPR87 (1.3), 
TGFBI (1.3), VSNL1 (1.2), CLCA2 (1.7), E48 (2), MKI67 (2), CKS2 (1.1), PRC1 (1.6), HLA-B (2.4), HLA-
B39 (2), HLA-C (1.1), HLA-Cw*1701 (2.9), HLA-E (1.6), D6S81E (1.7), CCNB1 (2.2), CCNB2 (1.7), 
CCND1 (1.3), CCND2 (3.3), CHEK1 (1.7), CDC6 (1.6).
TGFβ/BMP-repressed factors MYC (1), MT1F (1.6), MT1G (1.1), UGP2 (1.6), CCND2 (3.3), KRT15 (1.2), VIL2 (3.3), CKMT1 (1), EHF 
(2.2), NIBAN (1.7), VAMP8 (3.2), TNNI2 (1.4), KLF4#.
WNT-induced factors MYC (1), CCNB1 (2.2), CCND1 (1.3), CCND2 (3.3), JUN (1), CKS2 (1.1), MKI67 (2), BIRC5 (2.5), 
TNNT1 (3.5), TNNI2 (1.4), MBNL (1.4), IGFBP3 (1.1), PTTG1 (1.1), EGFR (1.2), EMP1 (2.1), CSPG6 
(2.8), CALD1 (1.2), BTEB2 (1.8), DUSP6 (3.5), FOS (2.2), JWA (1.2), HSP70 (1.4), KRT5 (1), GSTM3 (1.3), 
NCOA3 (1.3), OSF2 (1.1), SDC4 (1), ELF1 (1.6), HMG14 (1), TRA1 (2.3), CDC6 (1.6), DHFR (1.1), 
ADE2H1 (2), NSAP1 (1.2), MCM4 (3.4), KPNB3 (1.2), KRTHA1 (0.5)#, MYCBP (0.6)#.
NF-κB-induced factors MYC (1), MT1F (1.6), MT1G (1.1), CCND1 (1.3), FTH1 (1.7), IGFBP1 (2), HMG14 (1), AKR1C2 (1), 
UGCG (1.1), GBP-1 (1.2), ATF3 (3.3), SDC4 (1), PTGS2 (1.3), BMP2 (1.3), DUSP6 (3.5), MGP (1.1), FOS 
(2.2), MCP-1 (5.4), PIG7 (2), MIF (1.8), PMAIP1 (1.3), LSR68 (3.6), TNFS10 (2.7), HLA-B (2.4), HLA-B39 
(2), HLA-C (1.1), HLA-Cw*1701 (2.9), HLA-E (1.6), D6S81E (1.7), HSPB1 (3).
Functional classification of some of the genes that are selectively upregulated ≥ 2 fold in α6+/MHCI+ cells relative to α6+/MHCI- cells (for the full list 
see Additional file 1). The numbers shown in parentheses are in log2 scale and are the highest score for that gene. Expression of the genes marked 
with (#) have been additionally verified (Figure 4).BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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Uupregulation of transcripts encoding bone morphogenic 
factors in α6+/MHCI- cells
It has been shown that TGF-β and the bone morphogenic
factors are upregulated in epidermal stem cells [9,31,33].
Consequently, hair follicle stem cells are enriched with
TGF-β/BMP targets [9]. In accordance with those findings,
we observed that transcripts of several genes whose prod-
ucts are necessary for the activation of TGF-β/phospho-
Smad pathway, such as genes necessary for latent TGF-β
activation (LTBP-1  and  LTBP-2), secreted activators
(BMP5, BMP8, BMP10, BMP15), and transcriptional acti-
vators of TGF-β responses (MADH3 and MADH6), were
enriched in α6+/MHCI-  cells compared to α6+/MHCI+
cells (Table 1). In addition, transcripts of forty-nine target
genes shown to be upregulated by TGF-β/BMP pathway
were more abundant in α6+/MHCI-  cells. Conversely,
transcripts of the genes whose expression is shown to be
suppressed by TGF-β/phospho-Smad pathway, including
transcription factors c-Myc and KLF4, were more abun-
dant in α6+/MHCI+ cells (Figure 3B, Table 2). Since TGFβ/
BMP pathway is tightly associated with stem cell quies-
cence [31,47,48], upregulation of BMPs in α6+/MHCI-
cells might explain why these cells exhibit characteristics
of quiescent cells.
Transcripts of Wnt receptors and Wnt signaling inhibitors 
are enriched in α6+/MHCI- cells
Wnt pathway plays an important role in hair follicle mor-
phogenesis and cycling [49-51]. Researchers found that
transcripts of several Wnt genes were downregulated in
the mouse hair follicle bulge stem cells. In addition,
higher levels of several genes that inhibit Wnt signaling
pathway as well as higher levels of transcripts of the Wnt
receptors were found in epidermal stem cells
[9,21,32,33]. In the same cells, in general, targets of Wnt
signaling (such as hair keratin, KRTHA1, nuclear prolifer-
ation antigen Ki67 [9,33,51] are downregulated. Consist-
ent with these observations, we found that WNT3 and
WNT4 were downregulated, while Wnt receptors FZD1,
FZD4, FZD7, and the inhibitors of Wnt signaling path-
way, DAB2, TCF3, CTBP2, WIF1, DKK1, and DKK2 were
upregulated in α6+/MHCI- cells (Table 1 and 2). Further-
more, transcripts of thirty eight genes that are known to be
upregulated by Wnt signaling pathway were less abundant
in α6+/MHCI- cells, including MYCBP and type I hair ker-
atin 1 (KRTHA1) (Figure 3B and Table 2). Also as expected
to be found in stem cells, transcripts of genes that are
downregulated by Wnt signaling pathway were found to
be more abundant in α6+/MHCI- cells. We found tran-
scripts of fourteen such genes in α6+/MHCI- cells (Table
2).
Transcripts of the markers implicated in mammalian 
growth/differentiation are downregulated in α6+/MHCI- 
cells compared to α6+/MHCI+ cells
Stem cells are the least differentiated cells in their tissue of
origin; therefore, transcription factors and signaling path-
ways that induce differentiation are expected to be down-
regulated in these cells. As mentioned above, we found
that MYC was less abundant in α6+/MHCI- cells compared
to α6+/MHCI+ cells (see Additional files 1 and 6). Upon
screening of our microarray database for c-Myc targets, we
found that the transcripts of sixty-one genes including
MYCBP  (Figure 3B and Additional file 6), which were
reported previously to be upregulated by c-Myc, were
upregulated in α6+/MHCI+ cells. Conversely, transcripts of
nineteen genes that were reported to be downregulated by
c-Myc were upregulated in α6+/MHCI- cells (see Addi-
tional file 6). Since many targets of c-Myc are involved in
the ribosomal biogenesis, the downregulation of MYC
may account for the observed downregulation of large
numbers of genes that are involved in ribosomal biogen-
esis in α6+/MHCI- cells (see Additional file 1), and may be
an additional evidence that the downregulation of MYC
in stem cells is related to their quiescent/undifferentiated
state.
Similar to c-MYC  expression, the expression of KLF4
(Kruppel-like factor 4), a transcription factor that is
mainly expressed in the differentiating layers of epidermis
CD71 expression in MHCI negative and MHCI positive cells Figure 4
CD71 expression in MHCI negative and MHCI posi-
tive cells. (A) showing A representative flow cytometry 
analysis of the expression of MHCI and CD71 indicating that 
epidermal cells that exhibit lack/low expression of MHCI also 
exhibit lower expression of CD71 than cells that express 
high level of MHCI. Gates were set using isotype control 
antibodies and single color antibodies. The geometrical mean 
channel fluorescence of the populations is indicated. (B) Sin-
gle positive control for PE. (C) Single positive control for 
FITC. (D) Isotype control.
A
C
B
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[52], and BMP2, a member of bone morphogenetic pro-
tein family that is mainly expressed in proliferative basal
and differentiated suprabasal keratinocytes [53], were
downregulated in α6+/MHCI-  cells compared to α6+/
MHCI+ cells (Table 2 and Additional file 1).
Notch1 signaling has been shown to stimulate differenti-
ation in mammalian skin [54]. Transcripts of the genes,
such as fillagrin, integrin alpha 6, loricrin, (FLG, INTA6,
LOR) whose expression is repressed by Nothch1 signaling
[54,55] were more abundant in α6+/MHCI- cells (Figure
3A, and Additional file 1). Furthermore, expression of
KRT5, which is upregulated by Notch1 signaling [54], was
more abundant in α6+/MHCI+ cells (Figure 3A, and see
Additional file 1). We investigated whether the levels of
Notch1 activity differ in α6+/MHCI- and α6+/MHCI+ cells.
By using flow cytometry analysis with an antibody specific
for cleaved/active Notch1, we could not detect any signif-
icant presence of cleaved/active Notch1 in α6+/MHCI-
cells contrary to α6+/MHCI+ cells (Figure 5), which indi-
cates that differentiation-inducing pathway Notch1 is
downregulated/inhibited in α6+/MHCI- cells.
It has been shown that Notch1 signaling pathway acti-
vates NF-κB pathway and upregulates subunits of NF-κB
and its targets [56-58]. Thus, we investigated whether the
levels of activity of NF-κB pathway, which is downstream
of Notch1 pathway, differ in MHCI- and MHCI+ cells.
First, we analyzed the expression of NF-κB subunit RelA in
MHCI- and MHCI+ cells and found a positive correlation
between the expression of NF-κB subunit RelA and MHCI
(Figure 6). Since both MHCI molecules and NF-κB subu-
nits are targets of NF-κB pathway, this result suggested
that similar to the Notch1 pathway, NF-κB pathway is
downregulated in MHCI- cells.
Search of our cDNA array data base for activators and tar-
gets of NF-κB pathway identified transcripts of genes,
which either directly activate NF-κB pathway, or play a
role in the activation of this pathway, such as BMP2 and
MALT1 [59], that were more abundant in α6+/MHCI+ cells
compared to α6+/MHCI- cells. Furthermore, in accordance
with this finding, transcripts of thirty genes that are
reported to be upregulated by Rel/NF-κB transcription fac-
tors [59], were enriched in α6+/MHCI+ cells (Table 2).
Thus, our microarray data suggest that the NF-κB pathway
is downregulated in α6+/MHCI- cells as compared to α6+/
MHCI+ cells. To determine whether NF-κB pathway is
indeed more active in α6+/MHCI+ cells, we performed
TRANS AM NF-κB ELISA assay using nuclear extracts of
α6+/MHCI+ and α6+/MHCI- cells. We found that the rela-
tive amount of nuclear phospho-NF-κB p50 bound to
DNA, an indicator of an active NF-κB pathway, is higher
in α6+/MHCI+ cells than α6+/MHCI- cells (Figure 7). Col-
lectively, the data demonstrate that Notch1 signaling as
well as the downstream NF-κB pathway are both down-
NF-κB activity in MHCI negative and MHCI positive cells Figure 6
NF-κB activity in MHCI negative and MHCI positive 
cells. (A) A representative flow cytometry analysis of the 
expression of MHCI and NF-κB subunit RelA/p65 proteins 
showing that epidermal cells that exhibit low expression of 
RelA/p65 also exhibit lack/low expression of MHCI. The geo-
metrical mean channel fluorescence of the populations is 
indicated. (B) Single positive control for PE. (C) Single posi-
tive control for FITC. (D) Secondary control.
A B
C D
Lack of Notch1 activity in MHCI negative cells Figure 5
Lack of Notch1 activity in MHCI negative cells. Figure 
demonstrating lack of cleaved/active Notch1 expression in 
α6+/MHCI- cells and its presence in α6+/MHCI+ The data are 
obtained by flow cytometry analysis using an antibody specific 
for cleaved/active Notch1.
Alpha6+/MHCI+ secondary control
Alpha6+/MHCI- secondary control
Alpha6+/MHCI+  cleaved Notch1
Alpha6+/MHCI- cleaved Notch1BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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regulated in α6+/MHCI- cells compared to α6+/MHCI+
cells.
The comparison of our data with the transcriptional 
profile of the genes that are differentially expressed in the 
basal and differentiating layers of the epidermis
To gain further insights of epidermal differentiation, we
compared our database with the published database of
differentially expressed genes in basal and suprabasal lay-
ers of the human epidermis [60]. The comparison of our
data with the transcriptional profile of the genes that are
differentially expressed in the basal and differentiated lay-
ers of the epidermis suggests that TGF-β/phospho-Smad
pathway-induced transcription profile fades along the epi-
dermal differentiation axis. The abundance of transcripts,
which are upregulated by TGF-β/phospho-Smad pathway
(such as COL6A1, LTBP2, MMP9, PLAT), decrease during
differentiation, from presumptive stem to transient
amplifying cells (basal layer) and further to cells of the
suprabasal layers, where these transcripts are present at
the lowest level. In addition, the transcript of MADH3, a
transcriptional activator of TGF-β responses, is also
increasingly downregulated. Conversely, abundance of
transcripts, which are downregulated by TGF-β/phospho-
Smad pathway (such as KLF4 and MYC), appear to posi-
tively correlate with the increase of epidermal differentia-
tion (Figure 8A).
On the other hand, the comparison suggests that Notch1
and Wnt pathway-induced transcription profiles
strengthen along the epidermal differentiation axis. Tran-
scripts of MYC and ELF1, which are upregulated by Wnt
signaling gradually increase. These findings are in accord-
ance with the previous reports, which demonstrate that
TGF-β/phospho-Smad pathway prevents keratinocyte dif-
ferentiation [48], and, conversely, Notch1 and Wnt path-
ways induce keratinocyte differentiation [54,61,62]. Thus,
it might be possible that while TGF-β/phospho-Smad
pathway is gradually downregulated, Wnt pathway
becomes increasingly more active during epidermal differ-
entiation. Nevertheless, further investigation is necessary
to validate this hypothesis. Similarly, while the transcrip-
tion of KRT1, which is upregulated by Notch1 signaling,
increases,  ITGA6  mRNA, which is downregulated by
Notch1 signaling, decreases in keratinocytes during differ-
entiation (Figure 8A). Several reports demonstrated that
suprabasal cells have higher Notch1 activity than basal
cells [55,63]. As already mentioned, employing flow
cytometry analysis and antibodies against cleaved/active
Notch 1, no detectable levels of cleaved/active Notch 1
was observed in MHCI- cells indicating the lack of Notch1
activity (Figure 5).
Interestingly, previous reports suggested that strong
adherence of stem cells to extracellular matrix-rich base-
ment membrane may be involved in retaining these cells
in their natural residence (niche) [52,64]. In accordance
Changes in the gene expression during epidermal differentia- tion Figure 8
Changes in the gene expression during epidermal dif-
ferentiation. (A) Genes that are gradually downregulated, 
or upregulated during epidermal differentiation. The EST* 
represents the Human clone 23933 mRNA (B) Genes that 
are upregulated in α6+/MHCI+ cells (TA cells), and subse-
quently downregulated in suprabasal cells.
DIFFERENTIATION
Į6+/MHCI- Į6+/MHCI+   
Basal
Suprabasal
BRD2
NFIB
THBD
PLAT
KLF4
LTBP2
MYC
MUC1
KRT1
ITGA6
DSG1
COL6A1
MBP
LAMA3
UGCG
MMP9
ELF1
MADH3
RBL2
CEACAM1
EST*
THRA
ADD3
ZNF278
BLMH
RGS19
RORA
KIAA0768
A
CCNB1, CCND2, RFC5, 
ZWINT, BLCAP, IGFBP3, 
ARL7, COL17A1, USP10, 
DUSP6, CALD1, RAB31, 
KRT5, PIG7, PTGS2, 
TIMP1, TGFBI, IGFBP3, 
PAFAH1B3, KIAA0159, 
PTTG1
B
DIFFERENTIATION
Į6+/MHCI- Į6+/MHCI+   
Basal
Suprabasal NF-κB activity in α6+/MHCI negative and MHCI positive cells Figure 7
NF-κB activity in α6+/MHCI negative and MHCI posi-
tive cells. Nuclear extracts of sorted cells were analyzed for 
NF-κB p50-binding activity; data were expressed in optical 
density (O.D.) units obtained with the TransAM ELISA NF-
κB assay for phosopho-p50 (**P < 0.017).BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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with these observations, the comparison of our data with
published transcription profiles of the basal and supraba-
sal cells of the epidermis revealed that during differentia-
tion transcripts of several genes (MUC1, COL6A1, ITGA6,
MMP9, PLAT, CEACAM1) whose products are soluble or
membrane-bound factors that play a role in the interac-
tion of cells with the microenvironment, decrease gradu-
ally during differentiation (Figure 8A).
We also found that twenty-one genes were upregulated in
α6+/MHCI+ cells (TA cells) alone, and later become down-
regulated during terminal differentiation (Figure 8B).
Among these transcripts there are ones related to cell cycle
(CCNB1, CCND2, RFC5) as well as mRNAs of the genes
whose products induce cell growth and division (ZWINT,
BLCAP). Since α6+/MHCI- cells are quiescent, and termi-
nally differentiating cells are post-mitotic it is not surpris-
ing to find transcripts whose products accelerates cell
proliferation among the genes that are upregulated only
in α6+/MHCI+ cells during epidermal differentiation. Sim-
ilarly, genes whose products suppress cell growth and pro-
liferation were enriched both in α6+/MHCI- cells and
terminally differentiating suprabasal cells, such as
PLAGL1, a zinc finger transcription factor that induces cell
cycle arrest in the skin and whose expression is dimin-
ished in basal cell carcinomas [65], putative tumor sup-
pressors insulin-like growth factor-binding protein 7
(IGFBP7), and DOC1 [66,67] (see Additional file 1 and
reference [60]).
Conclusion
Most of our knowledge regarding epidermal stem cells
comes from murine studies. This is the first report that
uncovers the transcriptional profile of human interfollic-
ular epidermal stem cells and their progeny, transient
amplifying cells isolated directly from their niches and
analyzed.
Table 2: Selected genes enriched in α6+/MHCI-cells compared to α6+/MHCI+cells.
mRNAs enriched in HHFSC TNRC9 (1.5), PHLDA1 (1), WIF-1 (6.6), RIG (1.6), DPYSL2 (1.9), DPYSL3 (1.4), GPM6B (2.5), FZD1 (1.3), 
NFATC1 (1.7), FST (2.3), DCT (2.5).
mRNAs enriched in MHFSC LHX2 (5), TCF3 (1.5), WIF-1 (6.6), TRPS1 (2), BACH2 (1.1), LTBP1 (1.1), LTBP2 (1), ID2 (1), ID4 (1), DPYSL2 
(1.9), DPYSL3 (1.4), GPR49 (2), GADD45G (1.2), ENPP1 (2.1), FBN2 (1), FOXC1 (1.7), VIM (1.7), DCT (2.5), 
MERTK (1.5), CRYM (1.5), CNR1 (1.4), SCD (2), TCF7 (1.1), CPE (1.9), EDNRB (2.8), AML1 (2.3), 
GPM6B(2.5), FGFR1 (2.5), CSPG2 (1.5), CSPG4 (2.1), NFATC1 (1.7), FYN (1.8), PRDM5 (1.5), ARG2 (1.4), 
MOX2 (2.9), DLX2 (1.8), ADAMTS5 (1.6), PHLDA1 (1), FZD7 (1.5), GUCY1B3 (1.5), TYR (2.1), COL1A2 (2), 
GPR64 (2.3), GSTM5 (1.2), PPAP2B (1.6), MITF (1.8), SNCAIP (1.2), SOX9 (1.9), MYH10 (1.1), MADH6 (1.6), 
INSIG1 (1.2), PLAT (1.4), PEG3 (2.8), NFIB (1.2), DAB2 (1.9), IGFBP5 (1.1), IGFBP7 (2.2), ITM2A (1.2), GFRA1 
(1.5), ALCAM (1.6), BDNF (2.6), SDF1 (1.1), COL3A1 ((1), COL4A1 (1.9), COL4A2 (1.8), COL5A1 (1.1), 
COL6A1 (1.1), COL14A1 (1.3), HXB (1.3), ACTN1 (1.1), HPGD (1.1), APP (1.2), CTBP2 (1), MYO1B (1.1), 
SIAT4C (1.5), EFNB2 (1.3), EDG2 (1.2), CYP1B1 (3.5), PRLR (1.1), ALDH7A1 (1.1), DCAMKL1 (1.6), PAK3 
(1.7).
TGFβ/BMP signaling MADH3 (1.3), MADH6 (1.6), MADHIP (1.5), FST (2.3), BMP5 (5.1), BMP8 (2), BMP10 (1.2). BMP15 (1.3), 
INHBC (1.8).
TGFβ/BMP-induced factors COL3A1 (1), COL4A1 (1.9), COL5A1 (1.1), COL6A1 (1.1), COL9A2 (1.6), COL11A1 (3.7), COL11A2 (1), 
COL14A1 (1.3), GPR56 (1.2), SOX4 (1.2), CLU (1.2), IQGAP1 (1.3), LMCD1 (2.7), SPRY4 (1.2), ITGB5 (1.1), 
LTBP1 (1), LTBP2 (1.1), GSN (1), PPAP2B (1.6), PEA15 (1.8), HEF1 (1.2), ID2 (1), ID4 (1), TGFB1l1 (1.3), 
FRZB (3.9), VCAM (1.2), FST (2), HXB (1.3), GSPG2 (2), AGC1 (1.5), THBS1 (2.3), APOE (1.1), MADH6 (1.6), 
NFATC1 (1.7), CKB (1.5), MMP9 (1.5), PLAUR (1.3), PLAT (1.4), APP (1.2), PTPRC (1.4), FZD1 (1.3), FYN 
(1.8), VAV1 (1.3), HCLS1 (1.1), TAL1 (1.1), LPL (1.3), BDNF (2.6), APBA3 (1.3), CDKN1C (2.1).
WNT signaling FRZB (3.9), FZD1 (1.3), FZD4 (1.7), FZD7 (1.5), WIF-1 (6.6), DKK1 (1.9), DKK2 (1.7), TCF3 (1.5), TCF7 
(1.1), TCFL2 (1.2), TLE1 (1), DAB2 (1.9), CTBP2 (1).
WNT-repressed factors ACTN3(1.1), AKAP12 (1.1), CTSB (1.4), PLA2G7 (3.1), LTBP2 (1), DAB2 (1.9), FST (2.3), CLU (1.2), TCF3 
(1.5), MEG3 (1.7), PPAP2B (1.6), LPL (1.3), ID4 (1), CDKN1C (2.1).
Interferon signaling IFNA5 (2.9), IFNA6 (4), IFNA7 (1.4), STAT2 (1.5), CIS4 (1), SSI-3 (1.6).
Inositol phospholipid signaling INPP4B (1.2), PIGB (1.2), PLCB4 (1), PLCE2 (1.4), KIAA0581 (2), GPLD1 (2.2), PIK3CD (1.2), NUDT4 (1.7), 
LOC51196 (1.7).
Functional classification of some of the genes that are selectively upregulated ≥ 2 fold in α6+/MHCI- cells relative to α6+/MHCI+ cells (for the full list 
see Additional file 1). The numbers shown in parentheses are in log2 scale and are the highest scores for that gene.BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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In summary, the results presented here show that α6+/
MHCI- cells exhibit characteristics attributed to stem cells.
Comparison of the transcription profiles of α6+/MHCI-
cells and α6+/MHCI+cells with the existing profiles of hair
follicle bulge stem cells further indicate that α6+/MHCI-
cells are enriched for stem cells. Our findings may bring
new insights into regulatory mechanisms involved in epi-
dermal homeostasis, and bring understanding of deregu-
lations of these mechanisms that take place in skin
disorders including cancer, and most importantly may
lead to identification of potential therapeutic targets. In
addition, as a first comprehensive gene expression profile
of putative human epithelial cells isolated directly from
tissue, the generated database may be of importance for
studies of gene expression profiles of other human epithe-
lial tissues. By defining characteristics of interfollicular
epidermal stem cells and by identifying genes whose
expression is altered during differentiation, we have
opened new roads for better understanding of stem cell
characteristics and epidermal differentiation.
Methods
Isolation of keratinocytes
Neonatal foreskins were obtained from routine circumci-
sions. After washing in PBS, and removing of subcutane-
ous fat, the tissue was cut into 5 × 5 mm pieces and
incubated overnight at 4°C in Dulbecco's modified
Eagle's medium containing 2.5 mg/ml Dispase II (Boe-
hringer Mannheim, Indianopolis, IN), penicillin (100
units per ml), and streptomycin (100 μg/ml). Epithelial
sheaths were separated from the dermis by gentle peeling
with forceps. Keratinocytes were harvested after incuba-
tion with trypsin/EDTA solution (0.05% and 0.01%,
respectively) for 10 minutes at 37°C [22].
Immunocytochemistry and flow cytometry
After trypsin neutralization and blocking with buffer con-
taining BSA and human IgG, keratinocytes were immu-
nolabeled with R-phycoerythrin (PE)-conjugated mouse
anti-human  β2 microglobulin (BD Biosciences, San
Diego, CA, USA), and with a monoclonal anti-human α6
integrin-fluorescein isothiocyanate (FITC) conjugate
(Serotec, Oxford, UK). Control samples were incubated
with appropriate isotype controls. All incubations were
performed at 4°C. Cells were sorted using FACSVantage,
or FACSAria (Becton Dickinson, Franklin Lakes, NJ). Flow
cytometry data used for sorting cells that donated RNA for
microarray experiments, as well as representative controls
are shown in Additional file 7. The data were analyzed
using Cell Quest software (BD Biosciences). Selection of
basal keratinocytes with anti-human α6 integrin elimi-
nates suprabasal cells (terminally differentiated keratino-
cytes), and non-keratinocytes, such as melanocytes and
dentritic cells) [21,60].
For the expression of Ki67 isolated keratinocytes were
immunolabeled with mouse anti-human antibody
against MHCI (BD Biosciences) and with a polyclonal
antibody against Ki67 (Zymed San Francisco, CA). Sec-
ondary antibodies were goat anti mouse IgG1 PE-conju-
gated antibody (Southern Biotechnology Associates Inc.
Birmingham, AL) and donkey anti rabbit FITC-conjugated
antibody. For the setting of gates, secondary control and
single color positive controls were used.
Keratinocyte culture
Keratinocytes were grown in a keratinocyte medium (3:1
DMEM, F12) supplemented with FBS and additives in 100
mm culture dishes, previously seeded with lethally irradi-
ated 3T3 fibroblasts [68]. The medium was replaced every
other day. Colonies were visualized after two weeks in cul-
ture following fixation in 10% formalin and staining with
2% rhodamine B (Sigma). Colony forming efficiency
(CFE) is the ratio of colony number to plating cell number
expressed as a percentage. Results are presented as means
± SD.
RNA isolation, amplification and microarray analysis
Following cell sorting, RNA isolation (RNeasy Mini Kit
(Qiagen)) and amplification (MessageAmp aRNA Kit
(Ambion)) microarray was performed using Affymetrix
HGU 133 A+B GeneChip set. Scanned images of Affyme-
trix GeneChip arrays were quantified using Affymetrix
GCOS software, Gene Chip Operating System. The target
intensity was set to 500 and the default parameters were
used. The results were filtered and probe sets with a "No
Change" (NC) call were removed. Additionally, probe sets
that were scored "Increased" (I) or "Marginal Increase"
(MI), but called absent on the experimental sample, as
well as probe sets that were scored Decreased (D) or "Mar-
ginal Decrease" (MD) and called absent in the baseline
sample, were removed. For the resulting list of probe sets
a fold change column was calculated. Microarray Gene
Expression Data have been deposited, accession number
GSE11089 [69]. For the genes that are differentially
expressed in both arrays see Additional files 2, 8 and 9.
Semi-quantative RT-PCR
Total RNA was isolated directly after cell sorting using the
RNeasy Mini Kit (QIAGEN) according to manufacturer's
protocol. Extracted RNA was reverse transcribed by using
Sensiscript RT Kit (QIAGEN) according to manufacturer's
instructions. It must be noted that RNA used for RT-PCR
and for each microarray analysis was isolated from cells
derived from multiple skin samples that consisted of dif-
ferent donors. By pooling skin samples we were able to
obtain sufficient amount of cells and at the same time
average any potential individual differences. Primers for
KRTHA1 [70], β-catenin [71], KLF4 [72], and DSG3 [73]
were published previously. Other primers used are: ITGA6BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
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F: 5'-TGCTGTTGGTTCCCTCTCAGAT-3'. ITGA6 R: 5'-
CTGGCGGAGGTCAATTCTGT-3'. MYCBP F: 5'-
ATGGCCCATTACAAAGCCGC-3'. MYCBP R: 5'-CTAT-
TCAGCACGCTTCTCCT-3'. Initial PCR step was 1 minute
at 94.0°C, followed by 25, 30, 35 cycles of a 15 seconds
melting at 94.0°C, a 15 seconds annealing at 55.0°C and
a 15 seconds extension at 72.0°C. The final extension was
at 72.0°C for 1 minute.
Validation of microarray data using immynocytochemistry 
and flow cytometry
For the analyses of protein expressions in MHCI- and
MHCI+ cells the following antibodies were used: Antibody
against MHCI, mouse anti-human (IgG1 isotype, BD bio-
sciences); antibody against NF-κB p65, rabbit anti human
(Santa Cruz); antibody against cleaved/active Notch1,
rabbit anti human (Calbiochem); and antibody against
CD71, mouse anti human (IgG1 isotype, Diaclone,
France). Secondary antibodies used for these analyses
were: FITC-conjugated goat anti-mouse IgM (Sigma), PE-
conjugated goat anti mouse IgG1 (SouthernBiotechnol-
ogy, Birmingham, Al), and FITC-conjugated donkey anti-
rabbit (Jackson ImmunoResearch Lab. Inc., West Grove,
PA).
Analysis of NF-κB activity using TransAM NF-κB p50 kit
Nuclear extracts were obtained using Nuclear Extract Kit
purchased from Active Motif (Carlsbad, CA). 100,000
cells (α6+/MHCI+  and  α6+/MHCI-  each) were directly
sorted in PBS buffer that contained phosphatase inhibi-
tors, supplied with the kit. Levels of the active/phospho-
NF-κB p50 in the nucleus were assayed using TransAM
NF-κB p50 Transcription Factor Assay Kit (Active Motif)
according to manufacturer's protocol. Nuclear extract of
HeLa cells stimulated with TNF-α for 30 minutes supplied
by Active Motif was used as a positive control.
Microarray data analysis
Additional file 1 contains all the transcripts, which dem-
onstrated equal or higher than 2 (≥ 2) fold difference
between  α6+/MHCI-  cells and α6+/MHCI+  cells (Addi-
tional file 1 shows only values that are ≥ 2 fold in log2
scale). The genes that are consistently downregulated or
upregulated in both arrays were shown in tables S6, S7
and S8. All transcripts that belong to MHCI protein family
are downregulated in α6+/MHCI- cells as expected, which
indicate that our selection process was successful (see
Additional file 1). Several reports were used as the base to
screen for c-Myc target genes [74-81], Wnt target genes
[82-93], TGF-β/BMP target genes [94-97], and targets of
NF-κB pathway [59,98-100].
Statistical analysis
Student's t-test was applied for statistical analysis. Error
bars represent ± SD.
Abbreviations
α6: integrin alpha 6; BMP: Bone Morphogenic Protein;
CDKN: cyclin dependent kinase inhibitor; CFE: colony
forming efficiency; IFN-α: interferon alpha; KRT: keratin;
MHCI: Major Histocompatibility Complex I; NF-κB:
Nuclear Factor kappa B; α6+/MHCI-; α6+/MHCI+ denote
keratinocytes sorted according to integrin alpha 6 and
MHCI expressions. MHCI- and MHCI+ denote total epi-
dermal cells that express or do not express MHCI.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MM designed and organized the study, performed cell iso-
lation and labeling for flow cytometry analysis and FACS
sorting, isolated RNA for microarray analysis, participated
in data analysis, manuscript drafting and revision. SSK
analyzed the microarray data, performed RT-PCR reac-
tions and NF-κB determination in isolated nuclei, pre-
pared figures and manuscript draft and was involved in
organization of the study and manuscript revision. SRS
participated in the design and organization of the study,
and manuscript revission. PMD participated in the analy-
sis of the microarray data and manuscript revision. MFB
participated in the analysis of the microarray data.
Additional material
Additional file 1
List of the genes that are differentially expressed in α6+/MHCI- cells and 
in α6+/MHCI+ cells. Entire Affymetrix probe set and their annotated 
genes that are up-regulated ≥ 2-fold in either α6+/MHCI- cells or α6+/
MHCI+ cells sorted according to their functions. Some of the genes are 
involved in multiple processes in the cell and could be placed in several 
tables. The table shows the difference in the expression α6+/MHCI+ cells 
vs. α6+/MHCI- cells. "-"sign indicates that the gene is upregulated in 
α6+/MHCI- cells. The numbers that show the difference in the level of 
gene expression are in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S1.pdf]
Additional file 2
List of the entire genes that are differentially expressed in either α6+/
MHCI+ cells or α6+/MHCI- cells and are consistently upregulated or 
down regulated in both arrays. "-"sign indicates that the gene is upregu-
lated in α6+/MHCI- cells. The numbers that show the difference in the 
level of gene expression are in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S2.pdf]BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
Page 13 of 15
(page number not for citation purposes)
Acknowledgements
Funding: This research was supported by grants USPHS/NIH/NIAMS K0-
1 AR02079 (MM) and R03 AR49936 (MM).
We thank members of Dr. Simon's lab, Microarray Core Facility at SUNY 
at Stony Brook, Microarray Core Facility at Cold cSpring Harbor Labora-
tory, and Flow Cytometry Core Facility at SUNY at Stony Brook for their 
help with this project.
References
1. Bickenbach JR, McCutecheon J, Mackenzie IC: Rate of loss of triti-
ated thymidine label in basal cells in mouse epithelial tissues.
Cell Tissue Kinet 1986, 19:325-333.
2. Christophers E: The architecture of stratum corneum after
wounding.  J Invest Dermatol 1971, 57:241-246.
3. Morris RJ, Fischer SM, Slaga TJ: Evidence that the centrally and
peripherally located cells in the murine epidermal prolifera-
tive unit are two distinct cell populations.  J Invest Dermatol
1985, 84:277-281.
4. Niemann C, Watt FM: Designer skin: lineage commitment in
postnatal epidermis.  Trends Cell Biol 2002, 12:185-192.
5. Bickenbach JR: Identification and behavior of label-retaining
cells in oral mucosa and skin.  J Dent Res 1981, 60:1611-1620.
6. Cotsarelis G, Sun TT, Lavker RM: Label-retaining cells reside in
the bulge area of pilosebaceous unit: implications for follicu-
lar stem cells, hair cycle, and skin carcinogenesis.  Cell 1990,
61:1329-1337.
7. Morris RJ, Potten CS: Highly persistent label-retaining cells in
the hair follicles of mice and their fate following induction of
anagen.  J Invest Dermatol 1999, 112:470-475.
8. Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM: Involvement of
follicular stem cells in forming not only the follicle but also
the epidermis.  Cell 2000, 102:451-461.
9. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M,
Fuchs E: Defining the epithelial stem cell niche in skin.  Science
2003, 303:359-363.
10. Jones PH, Watt FM: Separation of human epidermal stem cells
from transit amplifying cells on the basis of differences in
integrin function and expression.  Cell 1993, 73:713-724.
11. Li A, Simmons PJ, Kaur P: Identification and isolation of candi-
date human keratinocyte stem cells based on cell surface
phenotype.  Proc Natl Acad Sci USA 1998, 95:3902-3907.
12. Matic M, Evans WH, Brink PR, Simon M: Epidermal stem cells do
not communicate through gap junctions.  J Invest Dermatol
2002, 118:110-116.
13. Yu Y, Flint A, Dvorin EL, Bischoff J: AC133-2, a novel isoform of
human AC133 stem cell antigen.  J Biol Chem 2004,
277:20711-20716.
14. Wan H, Stone MG, Simpson C, Reynolds LE, Marshall JF, Hart IR,
Hodivala-Dilke KM, Eady RA: Desmosomal proteins, including
desmoglein 3, serve as novel negative markers for epidermal
Additional file 3
List of the genes that are differentially expressed in α6+/MHCI+cells vs. 
α6+/MHCI- cells and also expressed in human hair follicle SCs (HHFSC). 
"-"sign indicates that the gene is upregulated in α6+/MHCI- cells. The 
numbers that show the difference in the level of gene expression are in log2 
scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S3.pdf]
Additional file 4
List of the genes that are differentially expressed in α6+/MHCI+cells vs. 
α6+/MHCI- cells and also expressed in murine hair follicle SCs 
(MHFSC). "-"sign indicates that the gene is upregulated in α6+/MHCI- 
cells. The numbers that show the difference in the level of gene expression 
are in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S4.pdf]
Additional file 5
Expression of TCF3 targets in α6+/MHCI- and α6+/MHCI+cells. The table 
shows the difference in the expression in α6+/MHCI+ cells vs. α6+/MHCI- 
cells. "-"sign indicates that the gene is upregulated in α6+/MHCI- cells. 
The numbers that show the difference in the level of gene expression are 
in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S5.pdf]
Additional file 6
Expression of MYC targets in α6+/MHCI- and α6+/MHCI+cells. The table 
shows the difference in the expression in α6+/MHCI+ cells vs. α6+/MHCI- 
cells. "-"sign indicates that the gene is upregulated in α6+/MHCI- cells. 
The numbers that show the difference in the level of gene expression are 
in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S6.pdf]
Additional file 7
Flow cytometry data of sorted cells that donated RNA for microarray 
experiments.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S7.pdf]
Additional file 8
List of the genes that are differentially expressed in α6+/MHCI+ cells and 
α6+/MHCIcells and are consistently upregulated or downregulated ≥ 2 
fold in both arrays. "-"sign indicates that the gene is upregulated in α6+/
MHCI- cells. The numbers that show the difference in the level of gene 
expression are in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S8.pdf]
Additional file 9
List of the genes that are differentially expressed in at least one array ≥ 2 
fold in either α6+/MHCI+ cells or α6+/MHCI- cells and are consistently 
upregulated or down regulated in both arrays. "-"sign indicates that the 
gene is upregulated in α6+/MHCI- cells. The numbers that show the dif-
ference in the level of gene expression are in log2 scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-359-S9.pdf]BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
Page 14 of 15
(page number not for citation purposes)
stem cell-containing population of keratinocytes.  J Cell Sci
2003, 116:4239-4248.
15. Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-
Eldor J, Reubinoff B, Mandelboim O, Benvenisty N: Proc Natl Acad Sci
USA 2002, 99:9864-9869.
16. Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ: Neural
progenitor cells lack immunogenicity and resist destruction
as allografts.  Stem Cells 2003, 21:405-416.
17. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-
Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich
S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM: Pluripotency
of mesenchymal stem cells derived from adult marrow.
Nature 2002, 418:41-49.
18. Kubota H, Avarbock MR, Brinster RL: Spermatogonial stem cells
share some, but not all, phenotypic and functional character-
istics with other stem cells.  Proc Natl Acad Sci USA 2003,
100:6487-6492.
19. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L,
F e r b e r  I ,  L e b k o w s k i  J ,  M a r t i n  T ,  M a d r e n a s  J ,  B h a t i a  M :  Human
embryonic stem cells possess immune-privileged properties.
Stem Cells 2004, 22:448-456.
20. Tian L, Catt JW, O'Neill C, King NJ: Expression of immunoglob-
ulin superfamily cell adhesion molecules on murine embry-
onic stem cells.  Biol Reprod 1997, 57:561-568.
21. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA,
Cotsarelis G: Capturing and profiling adult hair follicle stem
cells.  Nat Biotechnol 2004, 22:411-417.
22. Matic M: A subpopulation of human basal keratinocytes has a
low/negative MHC class I expression.  Hum Immunol 2005,
66:962-968.
23. Blumenberg M, Tomic-Canic M: Human epidermal keratinoc-
ytes: keratinization processes.  I n  Formation and Structure of
Human Hair Volume 78. Edited by: Jolles P, Zahn H, and Hocker H.
Basel: Birkhauser Verlag; 1987:1-29. 
24. Fuchs E: Epidermal differentiation: the bare essentials.  J Cell
Biol 1990, 111:2807-2814.
25. Matic M, Petrov IN, Chen S, Wang C, Dimitrijevich SD, Wolosin JM:
Stem cells of the corneal epithelium lack connexins and
metabolite transfer capacity.  Differentiation 1997, 61:251-260.
26. Nilsson K, Evrin PE, Welsh KA: Production of beta-2-microglob-
ulin by normal and malignant human cell lines and periph-
eral lymphocytes.  Transplant Rev 1974, 21:53-84.
27. Jimbow K, Roth SI, Fitzpatrick TB, Szabo G: Mitotic activity in non-
neoplastic melanocytes in vivo as determined by histochem-
ical, autoradiographic, and electron microscope studies.  J
Cell Biol 1975, 66:663-670.
28. Moll I: Differential epithelial outgrowth of plucked and micro-
dissected human hair follicles in explant culture.  Arch Dermatol
Res 1996, 288:604-610.
29. Umemoto T, Yamato M, Nishida K, Yang J, Tano Y, Okano T: Limbal
epithelial side-population cells have stem cell-like proper-
ties, including quiescent state.  Stem Cells 2006, 24:86-94.
30. Barrandon Y, Green H: Three clonal types of keratinocyte with
different capacities for multiplication.  Proc Natl Acad Sci USA
1987, 84:2302-2306.
31. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E: Self-
renewal, multipotency, and the existence of two cell popula-
tions within an epithelial stem cell niche.  Cell 2004,
118:635-648.
32. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA,
Hopping SB, Brady JN, Udey MC, Vogel JC: Characterization and
isolation of stem cell-enriched human hair follicle bulge cells.
J Clin Invest 2006, 116:249-260.
33. Rhee H, Polak L, Fuchs E: Lhx2 maintains stem cell character in
hair follicles.  Science 2006, 312:1946-1949.
34. Schlotzer-Schrehardt U, Kruse FE: Identification and characteri-
zation of limbal stem cells.  Exp Eye Res 2005, 81:247-264.
35. Gosselet FP, Magnaldo T, Culerrier RM, Sarasin A, Ehrhart JC: BMP2
and BMP6 control p57 (Kip2) expression and cell growth
arrest/terminal differentiation in normal primary human
epidermal keratinocytes.  Cell Signal 2007, 19:731-739.
36. Ruas M, Peters G: The p16INK4a/CDKN2A tumor suppressor
and its relatives.  Biochim Biophys Acta 1998, 1378:F115-177.
37. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-
dependent kinases.  Genes Dev 1995, 9:1149-1163.
38. Gronthos S, Simmons PJ: The growth factor requirements of
STRO-1-positive human bone marrow stromal precursors
under serum-deprived conditions in vitro.  Blood 1995,
85:929-940.
39. Hatzfeld A, Eid P, Peiffer I, Li ML, Barbet R, Oostendorp RA, Haydont
V, Monier MN, Milon L, Fortunel N, Charbord P, Tovey M, Hatzfeld
J, Hatzfeld A: A sub-population of high proliferative potential-
quiescent human mesenchymal stem cells is under the
reversible control of interferon alpha/beta.  Leukemia 2007,
21:714-724.
40. Lim R, Knight B, Patel K, McHutchison JG, Yeoh GC, Olynyk JK: Anti-
proliferative effects of interferon alpha on hepatic progeni-
tor cells in vitro and in vivo.  Hepatology 2006, 43:1074-1083.
41. Wang JC, Lang HD, Liao P, Wong A: Recombinant alpha-inter-
feron inhibits colony formation of bone marrow fibroblast
progenitor cells (CFU-F).  Am J Hematol 1992, 40:81-85.
42. Quinlan LR: Phosphoinositides, inositol phosphates, and phos-
pholipase C in embryonic stem cells.  Methods Mol Biol 2006,
329:127-149.
43. Jensen KB, Watt FM: Single-cell expression profiling of human
epidermal stem and transit-amplifying cells: Lrig1 is a regu-
lator of stem cell quiescence.  Proc Natl Acad Sci USA 2006,
103:11958-11963.
44. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bon-
danza S, Ponzin D, McKeon F, De Luca M: p63 identifies keratino-
cyte stem cells.  Proc Natl Acad Sci USA 2001, 98:3156-3161.
45. Gandarillas A, Watt FM: c-Myc promotes differentiation of
human epidermal stem cells.  Genes Dev 1997, 11:2869-2882.
46. Nguyen H, Rendl M, Fuchs E: Tcf3 governs stem cell features and
represses cell fate determination in skin.  Cell 2006,
127:171-183.
47. Kobielak K, Stokes N, de la Cruz J, Polak L, Fuchs E: Loss of a qui-
escent niche but not follicle stem cells in the absence of bone
morphogenetic protein signaling.  Proc Natl Acad Sci USA 2007,
104:10063-10068.
48. Zhang J, He XC, Tong WG, Johnson T, Wiedemann LM, Mishina Y,
Feng JQ, Li L: Bone morphogenetic protein signaling inhibits
hair follicle anagen induction by restricting epithelial stem/
progenitor cell activation and expansion.  Stem Cells 2007,
24:2826-2839.
49. Blanpain C, Fuchs E: Epidermal stem cells of the skin.  Annu Rev
Cell Dev Biol 2006, 22:339-373.
50. DasGupta R, Fuchs E: Multiple roles for activated  LEF/TCF
transcription complexes during hair follicle development
and differentiation.  Development 1999, 126:4557-4568.
51. Jamora C, DasGupta R, Kocieniewski P, Fuchs E: Links between sig-
nal transduction, transcription and adhesion in epithelial bud
development.  Nature 2003, 422:317-322.
52. Segre JA, Bauer C, Fuchs E: Klf4 is a transcription factor
required for establishing the barrier function of the skin.  Nat
Genet 1999, 22:356-360.
53. Park GT, Marosso MI: Bone morphogenetic protein-2 (BMP-2)
transactivates Dlx3 through Smad1 and Smad4: alternative
mode for Dlx3 induction in mouse keratinocytes.  Nucleic Acids
Res 2002, 30:515-522.
54. Radtke F, Raj K: The role of Notch in tumorigenesis: oncogene
or tumour suppressor?  Nat Rev Cancer 2003, 3:756-3767.
55. Blanpain C, Lowry WE, Pasolli HA, Fuchs E: Canonical notch sign-
aling functions as a commitment switch in the epidermal lin-
eage.  Genes Dev 2006, 20:3022-3035.
56. Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele
L, Gabrilovich DI: Notch-1 regulates NF-kappaB activity in
hemopoietic progenitor cells.  J Immunol 2001, 167:4458-4467.
57. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L:
Jagged-1 mediated activation of notch signaling induces
complete maturation of human keratinocytes through NF-
kappaB and PPARgamma.  Cell Death Differ 2002, 9:842-855.
58. Oswald F, Liptay S, Adler G, Schmid RM: NF-kappaB2 is a putative
target gene of activated Notch-1 via RBP-Jkappa.  Mol Cell Biol
1998, 18:2077-2088.
59. Pahl HL: Activators and target genes of Rel/NF-kappaB tran-
scription factors.  Oncogene 1999, 18:6853-6866.
60. Radoja N, Gazel A, Banno T, Yano S, Blumenberg M: Transcrip-
tional profiling of epidermal differentiation.  Physiol Genomics
2006, 27:65-78.BMC Genomics 2008, 9:359 http://www.biomedcentral.com/1471-2164/9/359
Page 15 of 15
(page number not for citation purposes)
61. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W: beta-
Catenin controls hair follicle morphogenesis and stem cell
differentiation in the skin.  Cell 2001, 105:533-545.
62. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H,
Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke
F, Dotto GP: Notch signaling is a direct determinant of kerat-
inocyte growth arrest and entry into differentiation.  EMBO J
2001, 20:3427-3436.
63. Lin MH, Kopan R: Long-range, nonautonomous effects of acti-
vated Notch1 on tissue homeostasis in the nail.  Dev Biol 2003,
263:343-359.
64. Alonso L, Fuchs E: Stem cells in the skin: waste not, Wnt not.
Genes Dev 2003, 17:1189-200.
65. Basyuk E, Coulon V, Le Digarcher A, Coisy-Quivy M, Moles JP, Gan-
darillas A, Journot L: The candidate tumor suppressor gene
ZAC is involved in keratinocyte differentiation and its
expression is lost in basal cell carcinomas.  Mol Cancer Res 2005,
3:483-492.
66. Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA,
Cohen A, Lasonder E, Stunnenberg HG: MBD2/NuRD and MBD3/
NuRD, two distinct complexes with different biochemical
and functional properties.  Mol Cell Biol 2006, 26:843-851.
67. Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q, Lv B, Hu H, Lin J, Cui
J, Di M, Dong J, Lai M: IGFBP7 plays a potential tumor suppres-
sor role in colorectal carcinogenesis.  Cancer Biol Ther 2007,
6:354-359.
68. Randolph RK, Simon M: Characterization of retinol metabolism
in cultured human epidermal keratinocytes.  J Biol Chem 1993,
268:9198-9205.
69. Gene Expression Omnibus (GEO)   [http://
www.ncbi.nlm.nih.gov/projects/geo]
70. Winter H, Hofmann I, Langbein L, Rogers MA, Schweizer J: A splice
site mutation in the gene of the human type I hair keratin
hHa1 results in the expression of a tailless keratin isoform.  J
Biol Chem 1997, 272:32345-32352.
71. Nakamura Y, Nawata M, Wakitani S: Expression profiles and func-
tional analyses of Wnt-related genes in human joint disor-
ders.  Am J Pathol 2005, 167(1):97-105.
72. Chiambaretta F, De Graeve F, Turet G, Marceau G, Gain P, Dastugue
B, Rigal D, Sapin V: Cell and tissue specific expression of human
Kruppel-like transcription factors in human ocular surface.
Mol Vis 2004, 10:901-909.
73. Nielsen K, Heegaard S, Vorum H, Birkenkamp-Demtroder K, Ehlers
N, Orntoft TF: Altered expression of CLC, DSG3, EMP3,
S100A2, and SLPI in corneal epithelium from keratoconus
patients.  Cornea 2005, 24:661-668.
74. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman
RN, Golup TR: Expression analysis with oligonucleotide
microarrays reveals that MYC regulates genes involved in
growth, cell cycle, signaling, and adhesion.  Proc Natl Acad Sci
USA 2000, 97:3260-3265.
75. Dang CV: c-Myc target genes involved in cell growth, apopto-
sis, and metabolism.  Mol Cell Biol 1999, 19:1-11.
76. Ghiselli G, Coffee N, Munnery CE, Koratkar R, Siracusa LD: The
cohesin SMC3 is a target the for beta-catenin/TCF4 transac-
tivation pathway.  J Biol Chem 2003, 278:20259-20267.
77. Guo QM, Malek RL, Kim S, Chiao C, He M, Ruffy M, Sanka K, Lee NH,
Dang CV, Liu ET: Identification of c-myc responsive genes
using rat cDNA microarray.  Cancer Res 2000, 60:5922-5928.
78. Menssen A, Hermeking H: Characterization of the c-MYC-regu-
lated transcriptome by SAGE: identification and analysis of
c-MYC target genes.  Proc Natl Acad Sci USA 2002, 99:6274-6279.
79. Neiman PE, Ruddell A, Jasoni C, Loring G, Thomas SJ, Brandvold KA,
Lee Rm, Burnside J, Delrow J: Analysis of gene expression during
myc oncogene-induced lymphomagenesis in the bursa of
Fabricius.  Proc Natl Acad Sci USA 2001, 98:6378-6383.
80. Schlosser I, Holzel M, Murnseer M, Burtscher H, Weidle UH, Eick D:
A role for c-Myc in the regulation of ribosomal RNA process-
ing.  Nucleic Acids Res 2003, 31:6148-6156.
81. Schuhmacher M, Kohlhuber F, Holzel M, Kaiser C, Burtscher H,
Jarsch M, Bornkamm GW, Laux G, Polack A, Weidle UH, Eick D: The
transcriptional program of a human B cell line in response to
Myc.  Nucleic Acids Res 2001, 29:397-406.
82. Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB,
Desai KV, Tann A, Petersen D, Green JE, Varmus HE: Changes in
gene expression during the development of mammary
tumors in MMTV-Wnt-1 transgenic mice.  Genome Biol 2005,
6:R84.
83. Jackson A, Vayssiere B, Garcia T, Newell W, Baron R, Roman-Roman
S, Rawadi G: Gene array analysis of Wnt-regulated genes in
C3H10T1/2 cells.  Bone 2005, 36:585-598.
84. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDou-
gald OA: Wnt signaling protects 3T3-L1 preadipocytes from
apoptosis through induction of insulin-like growth factors.  J
Biol Chem 2002, 277:38239-38244.
85. Lowr y W E, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E:
Defining the impact of beta-catenin/Tcf transactivation on
epithelial stem cells.  Genes Dev 2005, 19:1596-1611.
86. Morkel M, Huelsken J, Wakamiya M, Ding J, Wetering M van de,
Clevers H, Taketo MM, Behringer RR, Shen MM, Birchmeier W:
Beta-catenin regulates Cripto- and Wnt3-dependent gene
expression programs in mouse axis and mesoderm forma-
tion.  Development 2003, 130:6283-6294.
87. Staal FJ, Weerkamp F, Baert MR, Burg CM van den, van Noort M, de
Haas EF, van Dongen JJ: Wnt target genes identified by DNA
microarrays in immature CD34+ thymocytes regulate prolif-
eration and cell adhesion.  J Immunol 2004, 172:1099-1108.
88. Taneyhill L, Pennica D: Identification of Wnt responsive genes
using a murine mammary epithelial cell line model system.
BMC Dev Biol 2004, 4:6.
89. Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, Dugger DL,
Winer J, Williams PM, Wieand D, Smith V, Schwall RH, Pennica D,
Polakis P: Synergistic induction of tumor antigens by Wnt-1
signaling and retinoic acid revealed by gene expression pro-
filing.  J Biol Chem 2002, 277:14329-14335.
90. Wetering M van de, Sancho E, Verweij C, de Lau W, Oving I, Hurl-
stone A, Horn K van der, Batlle E, Coudreuse D, Haramis AP, Tjon-
Pon-Fong M, Moerer P, Born M van den, Soete G, Pals S, Eilers M,
Medema R, Clevers H: The beta-catenin/TCF-4 complex
imposes a crypt progenitor phenotype on colorectal cancer
cells.  Cell 2002, 111:241-250.
91. Willert J, Epping M, Pollack JR, Brown PO, Nusse R: A transcrip-
tional response to Wnt protein in human embryonic carci-
noma cells.  BMC Dev Biol 2002, 2:8.
92. Ziegler S, Rohrs S, Tickenbrock L, Moroy T, Klein-Hitpass L, Vetter
IR, Müller O: Novel target genes of the Wnt pathway and sta-
tistical insights into Wnt target promoter regulation.  FEBS J
2005, 272:1600-1615.
93. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler
M: Target genes of the WNT/beta-catenin pathway in Wilms
tumors.  Genes Chromosomes Cancer 2006, 45:565-574.
94. Clancy BM, Johnson JD, Lambert AJ, Rezvankhah S, Wong A, Resmini
C, Feldman JL, Leppanen S, Pittman DD: A gene expression profile
for endochondral bone formation: oligonucleotide microar-
rays establish novel connections between known genes and
BMP-2-induced bone formation in mouse quadriceps.  Bone
2003, 33:46-63.
95. Kang Y, Chen CR, Massague J: A self-enabling TGFbeta response
coupled to stress signaling: Smad engages stress response
factor ATF3 for Id1 repression in epithelial cells.  Mol Cell
2003, 11:915-926.
96. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY,
Haydon RC, He TC: Transcriptional characterization of bone
morphogenetic proteins (BMPs)-mediated osteogenic sign-
aling.  J Cell Biochem 2003, 90:1149-1165.
97. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: TGF-
beta and the Smad signaling pathway support transcrip-
tomic reprogramming during epithelial-mesenchymal cell
transition.  Mol Biol Cell 2005, 16:1987-2002.
98. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhof-
fer M, Ørntoft T, Eizirik DL: A comprehensive analysis of
cytokine-induced and nuclear factor-kappa B-dependent
genes in primary rat pancreatic beta-cells.  J Biol Chem 2001,
276:48879-48886.
99. Li X, Massa PE, Hanidu A, Peet GW, Aro P, Savitt A, Mische S, Li J,
Marcu KB: IKKalpha, IKKbeta, and NEMO/IKKgamma are
each required for the NF-kappa B-mediated inflammatory
response program.  J Biol Chem 2002, 277:45129-45140.
100. Tian B, Nowak DE, Jamaluddin M, Wang S, Brasier AR: Identifica-
tion of direct genomic targets downstream of the nuclear
factor-kappaB transcription factor mediating tumor necro-
sis factor signaling.  J Biol Chem 2005, 280:17435-17448.